PTIE Insider Trading Activity and SEC Form 4 Filings
PTIE insider trading summary
No open-market insider purchases or sales of Pain Therapeutics Inc (PTIE) have been reported on SEC Form 4 in the past 12 months.
Latest PTIE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 3, 2018 | Armistice Capital, LLC | 10% Owner | Sell | $672K (512,660 @ $1.31) |
| Oct 3, 2018 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $672K (512,660 @ $1.31) |
| Oct 3, 2018 | Armistice Capital, LLC | 10% Owner | Sell | $0 (0 @ $0.00) |
| Oct 3, 2018 | Steven Boyd | 10% Owner | Sell | $0 (0 @ $0.00) |
| Oct 3, 2018 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $0 (0 @ $0.00) |
| Oct 3, 2018 | Steven Boyd | 10% Owner | Sell | $672K (512,660 @ $1.31) |
| Sep 27, 2018 | Sanford Robertson | Director | Buy | $40K (37,817 @ $1.05) |
| Sep 26, 2018 | Sanford Robertson | Director | Buy | $33K (30,992 @ $1.05) |
| Sep 25, 2018 | Sanford Robertson | Director | Buy | $21K (21,420 @ $1.00) |
| Sep 24, 2018 | Sanford Robertson | Director | Buy | $9K (9,771 @ $0.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.